JMDC

Flixy Inc. is a Tokyo-based company that specializes in the development and sale of medical and healthcare software services. Founded in 2016, Flixy focuses on transforming the content of patient interviews into standardized medical terminology, thus enhancing communication and efficiency within healthcare settings. As of March 2020, Flixy operates as a subsidiary of JMDC Inc.

Heartseed Inc., founded in 2015 and based in Tokyo, Japan, focuses on developing myocardial regeneration medicine utilizing induced pluripotent stem (iPS) cells. The company aims to advance the clinical application of regenerative medicine specifically for treating heart disease. Heartseed is dedicated to creating cardiomyocyte replacement therapies derived from iPS cells to address advanced heart failure, aspiring to transform the treatment landscape for patients suffering from this condition.

Clintal Co., Ltd. is a Tokyo-based company that operates an online healthcare consultation platform established in 2015. The platform focuses on providing users with detailed information about qualified medical professionals, referred to as "good doctors," selected by specialists in various fields. Through its chat application, Clintal enables users to describe their symptoms and receive diagnoses based on a comprehensive database of medical data, including the number of surgeries performed and relevant articles. Additionally, the platform assists individuals in locating nearby clinics, facilitating easier access to appropriate medical care and treatment options.